Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)

sperm injection (ICSI) using a long gonadotropin-releasing hormone (GnRH) agonist protocol versus a short GnRH antagonist protocol.

follicle stimulating hormone
endometriosis
body mass index
gonadotropin releasing hormone antagonist
intracytoplasmic sperm injection
  • 25 views
  • 25 Jan, 2021
  • 23 locations
Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH

reproductive technique. This prospective study will do to evaluate the efficacy of gonadotropin releasing hormone antagonist in comparison with the standard long protocol in the

ganirelix
gonadotropin
hormone antagonist
reproductive techniques
gonadorelin
  • 22 views
  • 07 Nov, 2020
  • 1 location
The Effect of Luteal Blood Progesterone Levels on Ongoing Pregnancy Rates

gonadotropin releasing hormone (GnRH) agonist trigger as a luteal phase support (Humaidan, 2010, 2013), the mid luteal P4 levels increased to 77-409 nmol/l and birth rates per transfer raised to %24.

  • 0 views
  • 25 Jan, 2021
  • 2 locations
Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer

The present investigation aims to evaluate the efficacy of an innovative protocol of controlled ovarian stimulation for breast cancer patients, who are candidates for fertility preservation. Currently, vitrification of oocytes and/or embryos after controlled ovarian stimulation is the most established method for female fertility preservation. However, this stimulation induces an …

follicle stimulating hormone
mastectomy
cancer
breast cancer
adjuvant chemotherapy
  • 0 views
  • 24 Jan, 2021
  • 1 location
Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS

Polycystic ovarian syndrome (PCOS) is most common endocrinologic disease in women of reproductive age with incidence of 6.6 ~ 8%. About fifty percent of the patients with PCOS manifest subfertility and significant proportion of these woman need assisted reproductive technology (ART). These patients are very sensitive to gonadotropins during conventional …

  • 13 views
  • 24 Jan, 2021
  • 2 locations
Menopause Effects on Vascular Function

The purpose of the study is to identify the independent effect of estradiol (E2) on endothelin-1 (ET-1) mediated vasomotor function in women. The study is the first step in recognizing the impact of ovarian hormones on the mechanisms that regulate vascular function in women to provide a better understanding of …

estrogen
hormone therapy
cancer
heart disease
diabetes
  • 40 views
  • 25 Jan, 2021
  • 1 location
Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response

Progestin can inhibit the pituitary LH surge during ovarian stimulation and various studies show progestin-primed ovarian stimulation (PPOS) is effective in blocking the LH surge in IVF. More and more centers in China are using PPOS because this regimen appears simpler and cheaper.A randomized trial to compare the effectiveness of …

ganirelix
cetrorelix
antral follicle count
pituitary
medroxyprogesterone 10 mg
  • 42 views
  • 24 Jan, 2021
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)

Gonadotropin Releasing Hormone (GnRH) secretion. GnRH is a hormone released by a small gland in the brain called the hypothalamus. When GnRH is released, it signals another gland in the brain, the pituitary

serum testosterone
sex hormones
testosterone level
kallmann syndrome
estradiol
  • 85 views
  • 03 Jan, 2021
  • 1 location
Prolonged Protocol of Early Follicular or Mid Luteal Phase

Due to the injection of gonadotropin releasing hormone agonist (GnRH-a) before controlled ovarian hyperstimulation (COH), the scheme of prolonged early follicular period protocol has obvious

controlled ovarian hyperstimulation
polycystic ovary syndrome
antral follicle count
gonadotropin
infertility
  • 5 views
  • 24 Jan, 2021
  • 1 location
Testing the Addition of the Drugs Apalutamide and Abiraterone Acetate With Prednisone to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer

This phase III trial studies how well adding apalutamide, abiraterone acetate, and prednisone to the usual hormone therapy and radiation therapy works compared to the usual hormone therapy and radiation therapy in treating patients with node-positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells …

prostatectomy
apalutamide
luteinizing hormone-releasing hormone agonist
choline
prednisone
  • 72 views
  • 17 Dec, 2020
  • 73 locations